Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses

Biological Psychiatry

Volumn 70, Issue 5, 2011, Pages 479-486

  Busquets Garcia, Arnau ^a   Puighermanal, Emma ^a   Pastor, Antoni ^b,c   De La Torre, Rafael ^a,c,d   Maldonado, Rafael ^a   Ozaita, Andrés ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d University Hospital of Santiago de Compostela   (Spain)

Author keywords

Anxiety; cannabinoid receptor 2 (CB2); endocannabinoid; memory; nociception; tolerance

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID 2 RECEPTOR; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ESTERASE INHIBITOR; JZL 184; RIMONABANT; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; TASK PERFORMANCE;

AMIDOHYDROLASES; ANALGESICS; ANIMALS; ANTI-ANXIETY AGENTS; ARACHIDONIC ACIDS; BENZAMIDES; BENZODIOXOLES; CARBAMATES; DRUG TOLERANCE; GLYCERIDES; HIPPOCAMPUS; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MONOACYLGLYCEROL LIPASES; PAIN MEASUREMENT; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECOGNITION (PSYCHOLOGY); TOR SERINE-THREONINE KINASES;

EID: 80051473369     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.04.022     Document Type: Article

References (48)

1. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol Rev 89 2009 309 380
2. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949 (Pubitemid 23026736)
3. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
4. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87 (Pubitemid 26374593)
5. D.K. Nomura, C.S. Hudak, A.M. Ward, J.J. Burston, R.S. Issa, and K.J. Fisher Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels Bioorg Med Chem Lett 18 2008 5875 5878
6. D. Fegley, S. Gaetani, A. Duranti, A. Tontini, M. Mor, G. Tarzia, and D. Piomelli Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): Effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 2005 352 358 (Pubitemid 40411361)
7. J.Z. Long, W. Li, L. Booker, J.J. Burston, S.G. Kinsey, and J.E. Schlosburg Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat Chem Biol 5 2009 37 44
8. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, and M.G. Cascio The endogenous cannabinoid system controls extinction of aversive memories Nature 418 2002 530 534 (Pubitemid 34851398)
9. K. Ahn, M.K. McKinney, and B.F. Cravatt Enzymatic pathways that regulate endocannabinoid signaling in the nervous system Chem Rev 108 2008 1687 1707 (Pubitemid 351796405)
10. R.G. Pertwee Cannabinoid receptors and pain Prog Neurobiol 63 2001 569 611 (Pubitemid 32115433)
11. M. Ranganathan, and D.C. D'Souza The acute effects of cannabinoids on memory in humans: A review Psychopharmacology (Berl) 188 2006 425 444 (Pubitemid 44498214)
12. C. Castellano, C. Rossi-Arnaud, V. Cestari, and M. Costanzi Cannabinoids and memory: Animal studies Curr Drug Targets CNS Neurol Disord 2 2003 389 402
13. S. Kathuria, S. Gaetani, D. Fegley, F. Valio, A. Duranti, and A. Tontini Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 2003 76 81 (Pubitemid 36098263)
14. J.E. Schlosburg, S.G. Kinsey, and A.H. Lichtman Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation AAPS J 11 2009 39 44
15. J.E. Schlosburg, J.L. Blankman, J.Z. Long, D.K. Nomura, B. Pan, and S.G. Kinsey Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat Neurosci 13 2010 1113 1119
16. C. Ledent, O. Valverde, G. Cossu, F. Petitet, J.F. Aubert, and F. Beslot Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice Science 283 1999 401 404
17. D. Ehninger, S. Han, C. Shilyansky, Y. Zhou, W. Li, and D.J. Kwiatkowski Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis Nat Med 14 2008 843 848
18. A. Ozaita, E. Puighermanal, and R. Maldonado Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain J Neurochem 102 2007 1105 1114 (Pubitemid 47174245)
19. R.G. Phillips, and J.E. LeDoux Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning Behav Neurosci 106 1992 274 285
20. E. Puighermanal, G. Marsicano, A. Busquets-Garcia, B. Lutz, R. Maldonado, and A. Ozaita Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling Nat Neurosci 12 2009 1152 1158
21. N.J. Broadbent, L.R. Squire, and R.E. Clark Spatial memory, recognition memory, and the hippocampus Proc Natl Acad Sci U S A 101 2004 14515 14520 (Pubitemid 39346780)
22. S.G. Kinsey, J.Z. Long, S.T. O'Neal, R.A. Abdullah, J.L. Poklis, and D.L. Boger Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain J Pharmacol Exp Ther 330 2009 902 910
23. F.A. Moreira, N. Kaiser, K. Monory, and B. Lutz Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors Neuropharmacology 54 2008 141 150 (Pubitemid 350299416)
24. L.J. Sim-Selley Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids Crit Rev Neurobiol 15 2003 91 119 (Pubitemid 38160440)
25. D. Piomelli The endocannabinoid system: A drug discovery perspective Curr Opin Investig Drugs 6 2005 672 679 (Pubitemid 40904037)
26. C.A. Hoeffer, and E. Klann mTOR signaling: At the crossroads of plasticity, memory and disease Trends Neurosci 33 2010 67 75
27. A. Sharma, C.A. Hoeffer, Y. Takayasu, T. Miyawaki, S.M. McBride, E. Klann, and R.S. Zukin Dysregulation of mTOR signaling in fragile × syndrome J Neurosci 30 2010 694 702
28. A. Caccamo, S. Majumder, A. Richardson, R. Strong, and S. Oddo Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: Effects on cognitive impairments J Biol Chem 285 2010 13107 13120
29. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, and S.L. Sensi Brain monoglyceride lipase participating in endocannabinoid inactivation Proc Natl Acad Sci U S A 99 2002 10819 10824
30. I. Katona, G.M. Urbán, M. Wallace, C. Ledent, K.M. Jung, and D. Piomelli Molecular composition of the endocannabinoid system at glutamatergic synapses J Neurosci 26 2006 5628 5637 (Pubitemid 44315254)
31. J. Kim, and B.E. Alger Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses Nat Neurosci 13 2010 592 600
32. I. Katona, B. Sperlágh, A. Sík, A. Kfalvi, E.S. Vizi, K. Mackie, and T.F. Freund Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons J Neurosci 19 1999 4544 4558 (Pubitemid 29241104)
33. R. Romero-Granados, A. Fontán-Lozano, J.M. Delgado-García, and A.M. Carrión From learning to forgetting: Behavioral, circuitry, and molecular properties define the different functional states of the recognition memory trace Hippocampus 20 2010 584 595
34. C. Mazzola, J. Medalie, M. Scherma, L.V. Panlilio, M. Solinas, and G. Tanda Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors Learn Mem 16 2009 332 337
35. P. Campolongo, B. Roozendaal, V. Trezza, V. Cuomo, G. Astarita, and J. Fu Fat-induced satiety factor oleoylethanolamide enhances memory consolidation Proc Natl Acad Sci U S A 106 2009 8027 8031
36. M.N. Hill, S. Patel, P. Campolongo, J.G. Tasker, C.T. Wotjak, and J.S. Bains Functional interactions between stress and the endocannabinoid system: From synaptic signaling to behavioral output J Neurosci 30 2010 14980 14986
37. S. Gaetani, P. Dipasquale, A. Romano, L. Righetti, T. Cassano, D. Piomelli, and V. Cuomo The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs Int Rev Neurobiol 85 2009 57 72
38. M.A. García-Gutiérrez, and J. Manzanares Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice J Psychopharmacol 25 2011 111 120
39. R. Russo, J. Loverme, G. La Rana, T.R. Compton, J. Parrott, and A. Duranti The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice J Pharmacol Exp Ther 322 2007 236 242 (Pubitemid 46956375)
40. J. Guindon, A. Guijarro, D. Piomelli, and A.G. Hohmann Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain [published online ahead of print December 30] Br J Pharmacol 2010 10.1111/j.1476-5381.2010.01192.x
41. P.S. Naidu, L. Booker, B.F. Cravatt, and A.H. Lichtman Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception J Pharmacol Exp Ther 329 2009 48 56
42. A. Tanimura, M. Yamazaki, Y. Hashimotodani, M. Uchigashima, S. Kawata, and M. Abe The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission Neuron 65 2010 320 327
43. R. Nyilas, L.C. Gregg, K. Mackie, M. Watanabe, A. Zimmer, A.G. Hohmann, and I. Katona Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia Eur J Neurosci 29 2009 1964 1978
44. R.L. Suplita 2nd, S.A. Eisenstein, M.H. Neely, A.M. Moise, and A.G. Hohmann Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia Neuropharmacology 54 2008 161 171 (Pubitemid 350299417)
45. A.A. Boucher, G.E. Hunt, J. Micheau, X. Huang, I.S. McGregor, T. Karl, and J.C. Arnold The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids Int J Neuropsychopharmacol 14 2011 631 643
46. A.G. Hohmann, R.L. Suplita, N.M. Bolton, M.H. Neely, D. Fegley, and R. Mangieri An endocannabinoid mechanism for stress-induced analgesia Nature 435 2005 1108 1112 (Pubitemid 40910518)
47. K.W. Falenski, A.J. Thorpe, J.E. Schlosburg, B.F. Cravatt, R.A. Abdullah, and T.H. Smith FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration Neuropsychopharmacology 35 2010 1775 1787
48. O. Valverde, A.G. Blommaert, M.C. Fournié-Zaluski, B.P. Roques, and R. Maldonado Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist Eur J Pharmacol 286 1995 79 93